medigraphic.com
ISSN 1029-3035 (Electronic)

2012, Number 1

<< Back Next >>

Mediciego 2012; 18 (1)

Clinical characterization of the diabetic retinopathy in diabetics type 2 taken care in the Retina Service of the Ophthalmological Center “Dr. Salvador Allende” Hospital from Havana

Pérez MME, Triana CI, Pérez RL, Isas CM

Language: Spanish
References: 18
Page:
PDF size: 107.40 Kb.


ABSTRACT

Diabetic retinopathy constitutes an important ocular health problem at world-wide level, independently of level of socioeconomic development of countries. In this study we proposed to identify clinical characteristics of this disease in diabetics type 2. A descriptive study of cross section was carried out in 120 patients with diabetic retinopathy, who went to Retina Service of the Ophthalmological Center “Dr. Salvador Allende” in 2008, that were divided in two groups: treated with insulin and treated with oral hypoglycemic. A total of 234 eyes were examined, (maximal visual acuity, indirect ophthalmoscopy, biomicroscopy of posterior segment, optical tomography and fluorescein angiography). In the main results we obtained a predominance of diabetic retinopathy in patients older than 60 years, feminine sex and more than 20 years of diabetics evolution. The advanced stages of retinopathy, macular edema clinically significant and the greater visual deficit predominated in the sub-group dealt with insulin. The diabetes control and monitoring by the ophthalmologist were inadequate in both subgroups. The results allowed concluding that it is a disease that requires tight metabolic control and periodic monitoring by an ophthalmologist.


REFERENCES

  1. Aiello LM, Cavallerano JD, Aiello LP, Bursell SE. Diabetic retinopathy. En: Guyer DR, Yannuzzi LA, Chang S. Retina Vitreous Macula. Saint Louis: Mosby; 2005. p. 316-44.

  2. Montes Silvana V, Saucedo Jorge M, Wojtownik T, Wilka N. Revisión de retinopatía diabética. Rev Postgrad Cátedra Med Univ Estat Buenos Aires [Internet]. 2008 [citado 18 May 2009]; 179(4): [aprox. 10 p.]. Disponible en: http://kinesio.med.unne.edu.ar/revista/revista179/4_179.pdf

  3. Joslin Diabetes Center. Public release March 22, 2005. Diabetic retinopathy. Statistics. [Internet]. 2005 [citado 27 Sep 2008] [aprox. 4 pantallas]. Disponible en: http://www.eurekalert.org/pub_releases/2005-03/jdc-jdc032205.php.

  4. Cuba. Oficina Nacional de Estadística. Cálculo y análisis por sexo y edades. La Habana: ONE; 2005.

  5. Rodríguez CA. La teoría de la transición demográfica. La Habana: MINSAP; 2005.

  6. Dirección Municipal de Salud del Cerro. Informe Estadístico Anual. La Habana; 2008. [documento no publicado].

  7. Boyd BF, Boyd S. Cirugía de vítreo y retina. Dominando las técnicas más avanzadas. Barcelona: Salvat; 2002.

  8. Davis MD, Fisher MR, Gangnon RE. Early treatment diabetic retinopathy study research group. Classification of diabetic retinopathy. ETDRS Report No. 18. Invest Ophthalmol Vis Sci. 1998; 39:23-52.

  9. Diabetes Control and Complications Trial Research Group. The relationship of glicemia exposure (HbAc) to the risk of development and progression of retinopathy. Diabetes. 1995; 44:968-89.

  10. 10.López Cardet R. Retinopatía diabética. Proyecto para evitar la ceguera por diabetes tratando la retinopatía diabética. La Habana: Editorial de Ciencias Médicas; 2004.

  11. 11.Klein R, Klein BE, Moss SE. The Wisconsin Epidemiological Study of Diabetic Retinopathy. Reporte IV. Retinal photocoagulation. Ophthalmology. 1997; 94:747-53.

  12. 12.Report of the Expert Committee of Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21(supl):519-55.

  13. 13.King H, Aubert RE, Herman WH. Global burden of diabetes.1995-2025: Prevalence. Numerical estimates and projections. Diabetes Care. 1998; 21(9):1414-31.

  14. 14.Fernández Domínguez CA. Nuevos tratamientos en retinopatía diabética. Arch Soc Esp Oftalmol. 2003; 78:525-8.

  15. 15.Ferris FL. How effective are treatments for diabetic retinopathy? J Am Med Ass. 1993; 269:1290- 1.

  16. 16.UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 Diabetes. Lancet. 1998; 52:837-53.

  17. 17.Center for Disease, Control and Prevention. National Diabetes Fact Sheet. Atlanta: CDC; 2007.

  18. 18.Muphy RP. Management of diabetic retinopathy. Am Fam Phys. 1995; 51:85-96.




2020     |     www.medigraphic.com